Journal of Cardiology and Heart Failure

José E. Herrera, was born in Porlamar Venezuela on October 20, 1953. Married, father of 3 children. Physician graduated from the University of the Andes, Mérida state, Venezuela. in 1977. Approval of the ECFMG USA exam (revalidation of medical degree) March 1979, Postgraduate in Cardiology (Doctor's Degree) at José Ignacio Baldó Hospital (Caracas-Venezuela) and in the University Hospital of Caracas, 1979-1980. Advanced Echocardiography Course at Thomas Jefferson University Hospital, Philadelphia, United States, 1984. He was a faculty at the meetings of the different TCT congresses 2014, 2015, 2016, USA, ICI Meeting held in Israel 2015, 2016, 2017, 2018, 2019, 2020, is  recepient the cardiovascular innovation award at the ICI 2015 meeting. He currently has 9 patents for medical device and PTCR procedure USA, Russia, Europe, Geneva and Japan. Scientific article published in the journal ESC Heart Failure 2022. He is a reviewer of the ESC Heart Failure and ACC Journal.

• Cardiovascular Diseases
• Heart Failure & Hemodynamics
• Interventional Cardiology & Device-Based Therapies
• Inferior Vena Cava (IVC) Dynamics and Preload Regulation
• Echocardiography and Cardiovascular Imaging

1. Medical Education & Training – Physician (University of the Andes, Venezuela, 1977); ECFMG Certification (USA, 1979); Postgraduate in Cardiology (José Ignacio Baldó Hospital & University Hospital of Caracas, 1979–1980); Advanced Echocardiography Course (Thomas Jefferson University Hospital, USA, 1984).
2. International Conference Faculty – Speaker/Faculty at TCT Congresses (USA, 2014–2016); Faculty at ICI Meetings (Israel, 2015–2020).
3. Awards – Recipient of the Cardiovascular Innovation Award, ICI Meeting, 2015.
4. Patents – Holder of 9 international patents for medical devices and PTCR procedure (USA, Russia, Europe, Geneva, Japan).
5. Editorial & Review Roles – Reviewer for ESC Heart Failure and ACC Journal.

1. Herrera JE. Percutaneous Transluminal Caval-flow Regulation PTCR®: An emerging therapy to reduce total cardiac burden in heart failure patients. Biomedical Research (Japan), 2023.
2. Herrera JE. Percutaneous Transluminal Caval-Flow Regulation PTCR®: A New Alternative Therapy to Reshape the Future Treatment of Heart Failure. European Society of Medicine Journal, Aug 2023.
3. Herrera JE. Percutaneous Transluminal Caval Flow Regulation PTCR®: A step forward in the evolution of the HFrEF treatment paradigm. Interventional Cardiology Open Access, Nov 2022.
4. Herrera JE. First-in-human experience of preload regulation with percutaneous transluminal caval flow regulation in heart failure with reduced ejection fraction patients. ESC Heart Failure, Jan 2022.
5. Herrera JE, et al. TCT-733 Acute Hemodynamic Effects of PTCR® with Balloon in Ischemic and Non-Ischemic Heart Failure Patients. J Am Coll Cardiol, 2015;66(15 Suppl):B299.
6. Herrera JE, et al. TCT-428 First PTCR® in a Patient with Congestive Heart Failure. J Am Coll Cardiol, 2014;64(11 Suppl):B125–B126.
7. Herrera JE. Estenosis dinámica de vena cava inferior: una nueva entidad clínica comparada con sanos. Revista Española de Cardiología (Supl.), 2012;65(3):294.
8. Herrera JE. A novel method to reduce preload mechanically in CHF patients: dynamic restriction of flow in the IVC. Eur J Heart Fail Supplements, 2011;10(Suppl S63).